Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Hims & Hers Health Inc (NY: HIMS ) 22.15 +0.59 (+2.74%) Official Closing Price Updated: 7:00 PM EDT, Oct 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Hims & Hers Health Inc < Previous 1 2 3 4 5 6 7 8 9 ... 16 17 Next > Why Hims & Hers' Incredible Growth Will Continue October 18, 2024 GLP-1s get all the attention, but Hims & Hers' core business is where the rocket growth is. Via The Motley Fool Hims & Hers Shares Have Rallied 22% This Week. Why That Move Is Now At Risk. October 16, 2024 Hims & Hers has enjoyed a rally on an FDA decision regarding Eli Lilly's tirzepatide. Via Investor's Business Daily Exposures Product Safety Hims & Hers to Announce Third Quarter 2024 Financial Results on November 4, 2024 October 14, 2024 From Hims & Hers Via Business Wire Hims & Hers Health Stock Is Popping Monday: What's Behind The Move? October 14, 2024 Hims & Hers Health Inc (NYSE:HIMS) shares are trading higher Monday after the U.S. Food and Drug Administration said it would reconsider a decision barring drug compounders from selling their own... Via Benzinga Hims & Hers Health Pops After FDA Allows Compounded Copies Of Eli Lilly's Obesity Drug October 14, 2024 An industry group sued the FDA, claiming tirzepatide remains in shortage. Via Investor's Business Daily Topics Lawsuit Exposures Financial Legal Product Safety What Is Going On With Hims & Hers Stock? October 11, 2024 Big GLP-1 news could have an impact. Via The Motley Fool How Is The Market Feeling About Hims & Hers Health? September 17, 2024 Via Benzinga Deep Dive Into Hims & Hers Health Stock: Analyst Perspectives (8 Ratings) September 13, 2024 Via Benzinga Where Does Hims & Hers Stock Go From Here? October 12, 2024 Is Hims & Hers in trouble since the FDA put a time clock on some GLP-1s, or is the future still bright? Via The Motley Fool Exposures Product Safety 2 Incredibly Cheap Growth Stocks to Buy Right Now October 12, 2024 Look beyond the stock price at the business when shares are volatile. Via The Motley Fool 2 No-Brainer Growth Stocks to Buy With $500 Right Now October 12, 2024 Consistently investing even moderate sums can grow your portfolio with time. Via The Motley Fool Top 3 Stocks with Explosive Call Option Activity: What to Watch October 10, 2024 Three stocks reported a surge in call option buying recently, showing investors that there could be a path to more upside potential, analysts agree Via MarketBeat FDA Sparks Controversy With Sudden Removal Of Eli Lilly's Weight Loss Drug From Shortage List October 08, 2024 FDA faces legal action after removing Tirzepatide from the shortage list without following required procedures, sparking concerns over patient access to the compounded diabetes and obesity treatment. Via Benzinga Exposures Product Safety Hims & Hers Stock Joins S&P 600: Is More Upside on the Horizon? October 08, 2024 There is now a new reason to look into Hims & Hers stock for additional upside, including the new addition to the S&P 600 index alongside double-digit growth. Via MarketBeat Topics Stocks Exposures US Equities With Its GLP-1 Drugs No Longer in a Shortage, Is Now the Time to Buy Eli Lilly Stock? October 08, 2024 Growth for its GLP-1 weight loss drugs continues to be robust. Via The Motley Fool 10 Health Care Stocks Whale Activity In Today's Session October 07, 2024 Via Benzinga Pfizer, Vista Outdoor, Duckhorn Portfolio And Other Big Stocks Moving Higher On Monday October 07, 2024 Via Benzinga Hims & Hers Health Stock Is Rising Monday: What's Going On? October 07, 2024 Hims & Hers Health Inc (NYSE:HIMS) shares are trading higher Monday. The company is set to join to the S&P SmallCap 600 this week. Via Benzinga Topics Stocks Exposures US Equities Hims & Hers Health Asserts Demand For Its Compounded Weight Loss Offering To Continue Despite Resolved Supply Shortages October 04, 2024 The FDA has resolved Eli Lilly's tirzepatide shortage, but localized supply issues persist. Meanwhile, Hims & Hers Health's Q3 2024 revenue is expected to exceed projections as concerns rise over... Via Benzinga Exposures Product Safety Massive News for Hims & Hers Stock: The Truth About Today's Move October 04, 2024 Hims & Hers may not be hurt by GLP-1 news the way investors think. Via The Motley Fool 2 Winning Growth Stocks That Are Screaming Buys Right Now October 04, 2024 These top stocks are on a winning streak and have the businesses to keep it going. Via The Motley Fool AngioDynamics, Ingevity, Levi Strauss And Other Big Stocks Moving Lower On Thursday October 03, 2024 Via Benzinga Hims & Hers Health Stock Is Tumbling Thursday: Here's Why October 03, 2024 Hims & Hers Health Inc (NYSE:HIMS) shares are trading lower Thursday after the U.S. Food and Drug Administration removed Eli Lilly And Co's (NYSE:LLY) weight-loss and diabetes drugs from its shortage... Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session October 03, 2024 Via Benzinga These 2 Healthcare Stocks With Big Catalysts on the Horizon Can Make You Richer October 02, 2024 Market-beating returns could be on the way for patient investors in these two up-and-coming healthcare growth stocks. Via The Motley Fool Hims & Hers To Offer Access To Compounded Diabetes And Weight Loss Drugs For Just $99/Month To Certain Professional Personnel September 19, 2024 Hims & Hers Health will offer compounded GLP-1 weight-loss medications for as low as $99 per month to eligible U.S. military personnel, veterans, teachers, nurses, and first responders. The telehealth... Via Benzinga Hims & Hers to Offer Access to Compounded GLP-1 Injections for as Low as $99/Month to U.S. Military, Veterans, Teachers, Nurses and First Responders September 18, 2024 From Hims & Hers Via Business Wire Hims & Hers Acquisition: How Innovation Will Flourish September 18, 2024 Buying a new pharmacy will allow Hims & Hers to expand into new markets. Via The Motley Fool 1 Telemedicine Stock I Wouldn't Touch With a 10-Foot Pole (Hint: It's Not Teladoc) September 17, 2024 Telemedicine once seemed like it was going to revolutionize healthcare. Via The Motley Fool Hims & Hers Stock Pops After Massive Acquisition September 13, 2024 The healthcare company will be making more of the product it sells. Via The Motley Fool < Previous 1 2 3 4 5 6 7 8 9 ... 16 17 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.